5-Fu + Cisplatin vs 5-FU + leucovorin + oxaliplatin (FOLFOX) with unsure stage roughly 2 or 3 - American Cancer Society

Don had both of those - he had chemo on Wednesdays and radiation 5 days a week. Lab draws every time prior to chemo. Don had some normal fatigue and really didn't feel good on the the 2nd day after the first chemo treatment. The following week the chemo ...

hair loss with Cisplatin and Topotecan - American Cancer Society

I am in the middle of a fight for my life. 'Had surgery in March to remove four tumors that were not responsive to chemo. They couldn't get the one, due to location, 'Had ten radiation chemos with three taxol "boosts" Now, on to the big stuff-cisplatin and ...

NOXA-Induced Alterations in the Bax/Smac Axis Enhance Sensitivity of Ovarian Cancer Cells to Cisplatin - Elites TV

Ovarian cancer is the most common cause of death from gynecologic malignancy. Deregulation of p53 and/or p73-associated apoptotic pathways contribute to the platinum-based resistance in ovarian cancer. NOXA, a pro-apoptotic BH3-only protein, is identified ...

Head and neck cancer: Cetuximab in combination with Docetaxel and Cisplatin as induction therapy - Xagena Medical News

Patients treated for locally advanced head and neck cancer may respond better to treatment with the addition of Cetuximab ( Erbitux ) to chemotherapy, according to a phase II study. In the study, 39 patients with stages 3 or 4 head and neck cancer were ...

Results from Boehringer Ingelheim’s LUX-Lung 3 Phase III trial on stage IIIB or IV NSCLC - News-Medical.Net

LUX-Lung 3, which compares the investigational oral, once-daily therapy, afatinib, to pemetrexed/cisplatin, is the largest Phase III trial to date in first-line EGFR mutation-positive, advanced, metastatic NSCLC patients, and the first to use ...

New understanding of 'copper pump' in cells could prime discovery of anti-cancer drugs - domain-b.com

The same pump transports the platinum-containing drug cisplatin into cancer cells to help kill them. Igor Tsigelny, a research scientist at the university's San Diego Supercomputer Centre and Department of Neurosciences, is lead author of the paper.

Boehringer Ingelheim to present pivotal Phase III results for afatinib in first-line treatment of EGFR mutation-positive NSCLC at ASCO 2012 - Yahoo Finance

LUX-Lung 3, which compares the investigational oral, once-daily therapy, afatinib, to pemetrexed/cisplatin, is the largest Phase III trial to date in first-line EGFR mutation-positive, advanced, metastatic NSCLC patients, and the first to use ...

'Copper pump's' potential benefit in cancer treatment - phys.org

Researchers have shown before that that human copper transporter 1 (hCTR1) protein also participates in transport of the platinum-containing cisplatin, one of the most widely used anti-cancer drugs. Once platinum-containing cisplatin molecules ...

Patients with muscle-invasive bladder cancer benefit from accelerated MVAC - News-Medical.Net

A large randomized clinical trial published in 2003 demonstrated a survival benefit for neoadjuvant, or pre-surgical, MVAC (methotrexate, vinblastine, doxorubicin and cisplatin) using a standard dose and schedule. However, in an effort to ...